title: Psychiatric illness and the serotonin syndrome: an emerging adverse drug effect leading to intensive care unit admission.
authors.affiliation: Yale University School of Medicine and Norwalk Hospital, Norwalk, CT, USA.
authors.forename: P K
authors.initials: PK
authors.lastname: Nijhawan
authors.forename: G
authors.initials: G
authors.lastname: Katz
authors.forename: S
authors.initials: S
authors.lastname: Winter
mesh_terms: D000430:Alcohol Withdrawal Delirium / Q000175:diagnosis; D002065:Buspirone / Q000009:adverse effects; D002997:Clomipramine / Q000009:adverse effects; D003937:Diagnosis, Differential; D004359:Drug Therapy, Combination; D005473:Fluoxetine / Q000009:adverse effects; D006760:Hospitalization; D006801:Humans; D008297:Male; D008875:Middle Aged; D009207:Myoclonus / Q000139:chemically induced* / Q000175:diagnosis; D009771:Obsessive-Compulsive Disorder / Q000188:drug therapy; D011619:Psychotropic Drugs / Q000009:adverse effects; D012701:Serotonin; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects*; D013577:Syndrome
chemical_list: D002065:Buspirone; D002997:Clomipramine; D005473:Fluoxetine; D011619:Psychotropic Drugs; D012701:Serotonin; D017367:Selective Serotonin Reuptake Inhibitors